T4U

(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Find entries where: T4U

is present as a standalone ligand in 3 entries

Find related ligands:

Chemical Component Summary
Name	(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
Synonyms	Lorcaserin
Identifiers	(5~{R})-7-chloranyl-5-methyl-2,3,4,5-tetrahydro-1~{H}-3-benzazepine
Formula	C₁₁ H₁₄ Cl N
Molecular Weight	195.689
Type	NON-POLYMER
Isomeric SMILES	C[C@H]1CNCCc2c1cc(cc2)Cl
InChI	InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1
InChIKey	XTTZERNUQAFMOF-QMMMGPOBSA-N

Chemical Details
Formal Charge	0
Atom Count	27
Chiral Atom Count	1
Bond Count	28
Aromatic Bond Count	6

Drug Info: DrugBank

DrugBank ID	DB04871
Name	Lorcaserin
Groups	approved withdrawn
Description	Lorcaserin (previously APD-356), a highly selective 5HT2C receptor agonist, is used for the treatment of obesity. It has been shown to reduce body weight and food intake in animal models of obesity, and it is thought that targeting the 5HT2C receptor may alter body weight by regulating satiety. Lorcaserin is marketed as a salt form called Belviq, which is lorcaserin hydrochloride. In February 2020, the FDA issued a Drug Safety Communication requesting the manufacturer of Belviq (lorcaserin hydrochloride tablets, 10 mg) and Belviq XR (lorcaserin hydrochloride extended-release tablets, 20 mg) to voluntarily withdraw these products from the U.S. market, and the company has submitted a request to voluntarily withdraw the drug. This decision was based on the results of a clinical trial assessing the risk of heart-related problems that found that patients treated with lorcaserin may have a higher risk of cancer.[L44042,L44047]
Synonyms	Lorcaserin hydrochloride hemihydrate Lorqess Lorcaserin hydrochloride Lorcaserin
Brand Names	Belviq Belviq XR
Indication	For the treatment of obesity, as an adjunct to a reduced-calorie diet and increased physical activity.
Categories	Alimentary Tract and Metabolism Antidepressive Agents Antiobesity Preparations, Excl. Diet Products Central Nervous System Depressants Centrally Acting Antiobesity Products Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP2A6 Substrates Cytochrome P-450 CYP2B6 Substrates Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (moderate) Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Heterocyclic Compounds, Fused-Ring Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin 2c Receptor Agonists Serotonin 5-HT2 Receptor Agonists Serotonin 5-HT2C Receptor Agonists Serotonin Agents Serotonin Modulators Serotonin Receptor Agonists
ATC-Code	A08AA11
CAS number	616202-92-7

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
5-hydroxytryptamine receptor 2C	MVNLRNAVHSFLVHLIGLLVWQCDISVSPVAAIVTDIFNTSDGGRFKFPD...	unknown
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	substrate
Cytochrome P450 2A6	MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLN...	unknown	substrate
Cytochrome P450 2B6	MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRG...	unknown	substrate
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	substrate
Cytochrome P450 2D6	MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...	unknown	substrate,inhibitor
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Dimethylaniline monooxygenase [N-oxide-forming] 1	MAKRVAIVGAGVSGLASIKCCLEEGLEPTCFERSDDLGGLWRFTEHVEEG...	unknown	substrate
Cytochrome P450 1A1	MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682